Morgan Stanley Maintains Equal-Weight on Elevance Health, Raises Price Target to $449
Benzinga Newsdesk 1 week ago
Analyst RatingsNewsPrice TargetHot
Morgan Stanley analyst Erin Wright maintains Elevance Health (NYSE:ELV) with a Equal-Weight and raises the price target from $404 to $449.
Morgan Stanley analyst Erin Wright maintains Elevance Health (NYSE:ELV) with a Equal-Weight and raises the price target from $404 to $449.